
Resmed Inc (RMD) Beta Value: Understanding the Market Risk
The price-to-earnings ratio for Resmed Inc (NYSE: RMD) is above average at 26.56x. The 36-month beta value for RMD is also noteworthy at 0.78. There
The price-to-earnings ratio for Resmed Inc (NYSE: RMD) is above average at 26.56x. The 36-month beta value for RMD is also noteworthy at 0.78. There
Resmed Inc (NYSE: RMD) has experienced a rise in its stock price by 0.17 compared to its previous closing price of 214.08. However, the company
The stock of Resmed Inc (RMD) has gone up by 4.61% for the week, with a -4.79% drop in the past month and a -6.49%
Resmed Inc (NYSE: RMD) has a higher price-to-earnings ratio of 24.87x compared to its average ratio. RMD has 36-month beta value of 0.80. Analysts have
Resmed Inc (NYSE: RMD) has experienced a decline in its stock price by -4.33 compared to its previous closing price of 223.00. However, the company
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.